344 related articles for article (PubMed ID: 17342321)
61. Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.
Hiraga J; Kinoshita T; Ohno T; Mori N; Ohashi H; Fukami S; Noda A; Ichikawa A; Naoe T
Int J Hematol; 2006 Oct; 84(3):248-55. PubMed ID: 17050200
[TBL] [Abstract][Full Text] [Related]
62. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
Kim CJ; Song JH; Cho YG; Cao Z; Lee YS; Nam SW; Lee JY; Park WS
Histopathology; 2008 Apr; 52(5):552-9. PubMed ID: 18312352
[TBL] [Abstract][Full Text] [Related]
63. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
64. Methylation of selected CpGs in the human O6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing.
Danam RP; Qian XC; Howell SR; Brent TP
Mol Carcinog; 1999 Feb; 24(2):85-9. PubMed ID: 10078935
[TBL] [Abstract][Full Text] [Related]
65. O6-Methylguanine-DNA methyltransferase hypermethylation modulated by 17beta-estradiol in lung cancer cells.
Lai JC; Wu JY; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Anticancer Res; 2009 Jul; 29(7):2535-40. PubMed ID: 19596925
[TBL] [Abstract][Full Text] [Related]
66. O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells.
Blough MD; Zlatescu MC; Cairncross JG
Cancer Res; 2007 Jan; 67(2):580-4. PubMed ID: 17234766
[TBL] [Abstract][Full Text] [Related]
67. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
[TBL] [Abstract][Full Text] [Related]
68. Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres.
Sciuscio D; Diserens AC; van Dommelen K; Martinet D; Jones G; Janzer RC; Pollo C; Hamou MF; Kaina B; Stupp R; Levivier M; Hegi ME
Clin Cancer Res; 2011 Jan; 17(2):255-66. PubMed ID: 21097691
[TBL] [Abstract][Full Text] [Related]
69. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS
Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893
[TBL] [Abstract][Full Text] [Related]
70. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
[TBL] [Abstract][Full Text] [Related]
71. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing.
Yau TO; Chan CY; Chan KL; Lee MF; Wong CM; Fan ST; Ng IO
Oncogene; 2005 Feb; 24(9):1607-14. PubMed ID: 15580286
[TBL] [Abstract][Full Text] [Related]
72. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J
Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111
[TBL] [Abstract][Full Text] [Related]
73. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.
Kanai Y; Hui AM; Sun L; Ushijima S; Sakamoto M; Tsuda H; Hirohashi S
Hepatology; 1999 Mar; 29(3):703-9. PubMed ID: 10051471
[TBL] [Abstract][Full Text] [Related]
74. Detailed methylation patterns and protein expression profiles of MGMT in colorectal carcinoma surgical margins.
Zhang D; Bai Y; Wang Y; Luo J; Ge Q; Qiao Y; Jia C; Lu Z
Clin Biochem; 2008 Jan; 41(1-2):19-25. PubMed ID: 18028895
[TBL] [Abstract][Full Text] [Related]
75. Review of genetic and epigenetic alterations in hepatocarcinogenesis.
Herath NI; Leggett BA; MacDonald GA
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):15-21. PubMed ID: 16706806
[TBL] [Abstract][Full Text] [Related]
76. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
[TBL] [Abstract][Full Text] [Related]
77. Change in expression of MGMT during maturation of human monocytes into dendritic cells.
Briegert M; Enk AH; Kaina B
DNA Repair (Amst); 2007 Sep; 6(9):1255-63. PubMed ID: 17382605
[TBL] [Abstract][Full Text] [Related]
78. Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma.
Rood BR; Zhang H; Cogen PH
Neuro Oncol; 2004 Jul; 6(3):200-7. PubMed ID: 15279712
[TBL] [Abstract][Full Text] [Related]
79. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of O6-methylguanine DNA methyltransferase activity in patients with gastric cancer.
Dinçer Y; Akçay T; Tortum OB; Alademir Z; Onen S; Doğusoy G
Oncol Res; 2003; 13(4):205-9. PubMed ID: 12659421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
